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Neonatal renal and inferior vena cava
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thrombotic vasculopathy: a case report
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Abstract
Background: Fetal thrombotic vasculopathy is a described placental diagnosis associated with adverse perinatal
outcomes. It may also predispose children to somatic thromboembolic events. As far as we know, this is the first
case of inferior vena cava thrombosis associated with fetal thrombotic vasculopathy in a completely asymptomatic
newborn.
Case presentation: We report the case of an asymptomatic, full-term Turkish male neonate delivered at 39 weeks
of gestation diagnosed as having thrombosis of the renal vein and inferior vena cava. Diagnosis was guided only
by the presence of edematous umbilical cord with macroscopic signs of clotting and, subsequently, microscopic
features of the placenta, suggesting fetal thrombotic vasculopathy.
Conclusions: Thrombosis of the renal and inferior vena cava in our healthy, asymptomatic full-term neonate is
clearly associated with fetal thrombotic vasculopathy. The diagnosis of thrombosis in this neonate was incidental.
This suggests that fetal thrombotic vasculopathy may cause unrecognized neonatal thrombosis. Untreated neonatal
thrombosis may later compromise growth and function of the involved organs; therefore, maintaining a high index
of suspicion based on thrombotic vasculopathy is paramount.
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Background
The vast majority of neonatal thromboembolic events
(TEs) are related to catheterization and most of their
discoveries are secondary to clinical manifestations [1].
Fetal thrombotic vasculopathy (FTV) is a recently
described placental diagnosis associated with adverse
perinatal outcomes. Neonates from mothers who have
FTV are more likely to have intracranial hemorrhage, co-
agulopathy, neurological impairment, growth retardation,
and evidence of systemic thrombosis/vasculopathy [2, 3].
We report the case of an otherwise healthy asymptomatic
neonate who was discovered to have thrombosis of
the inferior vena cava (IVC) on imaging. An ultra-
sound was performed on the baby due to edema and
macroscopic signs of thrombosis observed in the
umbilical cord. The placenta histologically showed
signs of FTV.
Case presentation
A full-term male Turkish neonate was delivered at
39 weeks of gestation by an urgent caesarian section due
to fetal heart rate decelerations, after a failed attempt of
vacuum-assisted vaginal delivery. The pregnancy of his
30-year-old gravida 4 para 2 mother had been uneventful.
She had previously experienced two spontaneous abor-
tions of unclear etiology. Their family history was negative
for coagulopathies.
The neonate was asymptomatic at birth, showing a
good transition to extrauterine life. An initial physical
examination revealed no pathologic findings; Apgar
scores were 7, 9, and 9 at 1, 5, and 10 minutes of life,
respectively, and arterial cord pH was 7.24. His body
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weight was 3420 grams, body length 52 cm, and head
circumference 34 cm. A neurological examination
revealed no abnormalities.
The obstetrician reported difficulties in clamping and
cutting the umbilical cord, which appeared edematous
and showed signs of clotting and hematoma (Fig. 1). On
macroscopic examination, the placenta showed signs of
FTV. On histologic examination, thrombosis of several
fetal vessels of the chorionic plate and avascular terminal
villi, including a macroscopic visible thrombosis of the
umbilical artery in an edematous umbilical cord, were
demonstrated (Figs. 2 and 3)
Despite his normal clinical appearance, an abdominal
ultrasound was performed to rule out any conditions
potentially related to placental FTV. The ultrasound
revealed a hyperechoic oval structure (8.5 × 4 mm) inside
his IVC near the conjunction of his renal veins, suggest-
ive of an intraluminal caval thrombus (Fig. 4). Of note, a
cranial ultrasonography revealed no abnormalities.
He was admitted to our neonatal division for clinical
monitoring and observation. In accordance with the
pediatric hematologist, anticoagulation with low-molecular-
weight heparin (enoxaparin) at a dose of 1.5 mg/kg twice a
day was started, targeting an anti-Xa between 0.5 and 1.0
U/ml [4].
Two days later, a second ultrasonography confirmed
the presence of a thrombus of 7.5 × 4 mm, extending
into his IVC from his right renal vein. His ipsilateral
kidney was slightly more hyperechoic with respect to the
left, suggesting parenchymal edema (Fig. 5). Magnetic
resonance imaging confirmed the diagnosis. His creatin-
ine reached a maximum value of 127 μmol/L on the
same day; this value is high for neonatal age [5] suggest-
ing initial renal vein involvement. His blood pressure
was always normal.
A third ultrasonography performed at day of life 7
showed a reduction in the size of the thrombus and
normalization of his kidney structure. Accordingly, his
creatinine decreased to normal values. He was discharged
at day of life 8, in good clinical condition and with enoxa-
parin to be continued for 3 months. Another ultrasound
examination at day of life 28 showed an almost complete
resolution of the thrombus (Fig. 6).
Thrombophilia screening in his mother showed a pro-
thrombin gene G20210A heterozygous mutation. Throm-
bophilia screening in the child was performed at 3 months
of age with normal results. He was in excellent clinical
condition at 1-year follow-up, and is thriving normally.
Discussion
TEs in infancy, both arterial and venous, are rare but
linked with a high risk of morbidity and mortality, which
is why several countries are collecting data on these
patients in national registries. Neonates have a higher in-
cidence of thrombosis as compared to older children. It
has been suggested that neonates are particularly suscep-
tible to such thrombotic complications, as they have
decreased levels of anticoagulants and lower levels of fi-
brinolytic components. The physiologic decrease in ac-
tivity at different levels of the hemostatic system usually
leads to a balance of the prothrombotic and antithrom-
botic components in healthy neonates.
In the literature, the reported incidence of symptom-
atic venous TEs ranges from 0.07 to 0.14/10,000 children
Fig. 1 Placenta and umbilical cord at birth
Fig. 2 Organized thrombus and recanalized stem villus (large photo
arrow); thrombus not completely organized (top right)
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and is 24/10,000 patients in neonatal intensive care units
[6–8]. Several studies based on national and inter-
national registries have evaluated the role of risk factors
for thrombosis both in children and neonates [6–8].
While the vast majority of venous TEs in neonates and
children are associated with the presence of central
venous lines, renal vein thrombosis represents the most
common non-catheter-related cause of venous TEs
occurring during the neonatal period [1]. The etiology of
renal vein thrombosis is not precisely known. Reported as-
sociated risk factors include perinatal asphyxia, maternal
diabetes, and infections [1]. To the best of our knowledge,
renal vein thrombosis associated with FTV has not been
reported so far.
FTV is a placental abnormality characterized by
clusters of not adequately vascularized villi that is
often related to upstream thrombosis in placental
fetal vessels [9]. On microscopic examination, FTV is
diagnosed by the presence of one or more throm-
bosed fetal vessels. In 2004, the Fetal Vascular
Obstruction Nosology Committee formally defined
FTV as the presence of 15 or more avascular villi or
Fig. 3 Stem villous vessels with thrombus (arrow) and stenosis (pictured left). Stem villous vessels normally pervious, for comparison (pictured right)
Fig. 4 Hyperechoic oval structure (8.5 × 4 mm) at the level of the inferior vena cava near to the opening of the renal veins suggestive of an
intraluminal caval thrombus
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villous stromal-vascular karyorrhexis in two or more foci
per slide, with or without an identifiable fetal vessel lesion
and in the absence of “villitis of unknown etiology with
stem villitis and avascular villi” [10]. On the basis of this
definition, the incidence of FTV in the several studies var-
ies from 1 to 6.4% [11]. The etiology and clinical features
of FTV are mostly unknown. Some conditions such as hy-
percoagulable state, endothelial damage, blood flow stasis,
maternal diabetes, and thrombophilia have been associ-
ated with FTV [12]. Obstructive cord abnormalities such
as excessively long or hypercoiled cord, entanglement,
true knots, marginal/membranous insertion, decreased
Wharton’s jelly, cord diameter < 8 mm are closely
associated with FTV and consequently to neonatal
thrombosis [9, 13].
Despite there being no consensus on the causes of
FTV, the adverse outcomes of this vasculopathy have
been described, raising an evolving concern. Intrauterine
growth retardation, fetal demise, intestinal atresia, and
thromboembolism into the fetal circulation probably
affecting liver, heart, and central nervous system are
included [14].
Fig. 5 Right kidney parenchyma appears more finely and diffusely hyperechoic than the left
Fig. 6 Top left: Thrombus at day of life 1. Top right: Initial reduction in the size of the thrombus on day of life 7. Bottom photo: Complete
regression of the thrombus at day of life 28
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Conclusions
Our case report stresses two important considerations.
First, thrombosis of the renal vein and IVC in our
healthy asymptomatic term neonate is clearly associated
with FTV. Thus, FTV should be included among the
reported causes of renal vein thrombosis in neonates.
Furthermore, the incidental nature of the diagnosis of
thrombosis in this neonate suggests that unrecognized
FTV possibly leads to unrecognized neonatal throm-
bosis, which in turn may compromise growth and
function of the involved organs. Our case underlines the
importance of macroscopic examination of the umbilical
cord and placenta at delivery. Suspected FTV should
lead to microscopic examination of the placenta and
ultrasound examination of the neonates to exclude
thrombosis of major vessels.
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